Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Markus Lucerna"'
Autor:
Renate B. Schnabel, Ladislav Pecen, Nargiz Rzayeva, Markus Lucerna, Yanish Purmah, Francisco M. Ojeda, Raffaele De Caterina, Paulus Kirchhof
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 11 (2018)
BackgroundLittle is known about the association of atrial fibrillation symptom burden with quality of life and outcomes. Methods and ResultsIn the Prevention of Thromboembolic Events–European Registry in Atrial Fibrillation (n=6196 patients with at
Externí odkaz:
https://doaj.org/article/5e21e95e5fe447dfa43292c00bdafa4e
Autor:
Giuseppe Patti, Markus Lucerna, Ladislav Pecen, Jolanta M. Siller‐Matula, Ilaria Cavallari, Paulus Kirchhof, Raffaele De Caterina
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 6, Iss 7 (2017)
BackgroundIncreasing age predisposes to both thromboembolic and bleeding events in patients with atrial fibrillation; therefore, balancing risks and benefits of antithrombotic strategies in older populations is crucial. We investigated 1‐year outco
Externí odkaz:
https://doaj.org/article/e779d492e437438a98de4649497784bf
Autor:
Erhard Hofer, Bernd R. Binder, Matthias Clauss, Markus Bischoff, Oswald Wagner, Johannes Breuss, Gernot Schabbauer, Yuri Sobanov, Martin Bilban, Florian Gruber, Alexandra Kadl, Diana Mechtcheriakova, Jiri Pomyje, Markus Lucerna
Supplementary Tables S1 & S2 from Sustained Expression of Early Growth Response Protein-1 Blocks Angiogenesis and Tumor Growth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a2582532e81f3a2da0e543e66398d16
https://doi.org/10.1158/0008-5472.22364582.v1
https://doi.org/10.1158/0008-5472.22364582.v1
Autor:
Erhard Hofer, Bernd R. Binder, Matthias Clauss, Markus Bischoff, Oswald Wagner, Johannes Breuss, Gernot Schabbauer, Yuri Sobanov, Martin Bilban, Florian Gruber, Alexandra Kadl, Diana Mechtcheriakova, Jiri Pomyje, Markus Lucerna
Transient induction of the transcription factor early growth response protein-1 (EGR-1) plays a pivotal role in the transcriptional response of endothelial cells to the angiogenic growth factors vascular endothelial growth factor (VEGF) and basic fib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4717abff342576dfefdad5a9eb2773f2
https://doi.org/10.1158/0008-5472.c.6494261.v1
https://doi.org/10.1158/0008-5472.c.6494261.v1
Autor:
Ladislav Pecen, Renate B. Schnabel, Raffaele De Caterina, Giuseppe Patti, Paulus Kirchhof, Jolanta M. Siller-Matula, Roberto Cemin, Kurt Huber, Markus Lucerna, Giulia Renda, Miklos Rohla
Publikováno v:
International Journal of Cardiology. 270:160-166
Background Evidence on whether antiPLT added to OACs is of advantage in atrial fibrillation (AF) patients with concomitant stable coronary artery disease (CAD) is limited. We evaluated clinical outcomes with oral anticoagulant (OAC) monotherapy vs an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b7a321231c677755479d88e93ad851c
https://doi.org/10.1016/j.ijcard.2018.06.098
https://doi.org/10.1016/j.ijcard.2018.06.098
Autor:
Jean-Yves Le Heuzey, Elisabetta Ricottini, Ilaria Cavallari, Ladislav Pecen, José Luis Zamorano, Raffaele De Caterina, Paulus Kirchhof, Markus Lucerna, Fabio Romeo, Giuseppe Patti, Giulia Renda
Publikováno v:
Journal of the American College of Cardiology. 69:409-419
Background Diabetes is a known risk predictor for thromboembolic events in patients with atrial fibrillation (AF), but no study has explored the prognostic weight of insulin in this setting. Objectives This study evaluated the differential role of in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d770a72a4ae17c35f02f563a0febd792
https://doi.org/10.1016/j.jacc.2016.10.069
https://doi.org/10.1016/j.jacc.2016.10.069
Autor:
Fabrizio Ricci, Giuseppe Patti, Jolanta M. Siller-Matula, Ladislav Pecen, Giulia Renda, Miklos Rohla, Markus Lucerna, Kurt Huber, Paulus Kirchhof, Raffaele De Caterina
Background The risks of thromboembolic and hemorrhagic events in patients with atrial fibrillation both increase with age; therefore, net clinical benefit analyses of anticoagulant treatments in the elderly population are crucial to guide treatment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43c7c8e71fd4ca6fdf65345fd1eb0463
http://hdl.handle.net/11697/134045
http://hdl.handle.net/11697/134045
Autor:
Ladislav Pecen, Fabrizio Ricci, Markus Lucerna, Jolanta M. Siller-Matula, Ilaria Cavallari, R. De Caterina, Giuseppe Patti, Giulia Renda, Miklos Rohla, Kurt Huber, P Kirkhhof
Publikováno v:
European Heart Journal. 39
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d2202c846c48b771ad81850b0fe91e7
https://doi.org/10.1093/eurheartj/ehy563.p3837
https://doi.org/10.1093/eurheartj/ehy563.p3837
Autor:
Jolanta M. Siller-Matula, Giuseppe Patti, Ladislav Pecen, R. De Caterina, Markus Lucerna, P Kirchhof
Publikováno v:
European Heart Journal. 38
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d25fc2c2f89d52776931fe315c089ace
https://doi.org/10.1093/eurheartj/ehx493.p4900
https://doi.org/10.1093/eurheartj/ehx493.p4900
Autor:
Jolanta M. Siller-Matula, Giuseppe Patti, Ladislav Pecen, R. De Caterina, Ilaria Cavallari, P Kirchhof, Markus Lucerna
Publikováno v:
European Heart Journal. 38
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5275924f98c11dac02c29d02b129e70f
https://doi.org/10.1093/eurheartj/ehx493.p5153
https://doi.org/10.1093/eurheartj/ehx493.p5153